Retractable Technologies (NYSE:RVP) Research Coverage Started at StockNews.com

StockNews.com initiated coverage on shares of Retractable Technologies (NYSE:RVP) in a report released on Sunday morning. The brokerage issued a hold rating on the stock.

Retractable Technologies Stock Performance

NYSE RVP opened at $0.80 on Friday. The firm has a market cap of $23.80 million, a P/E ratio of -1.47 and a beta of 1.96. The company has a quick ratio of 5.92, a current ratio of 8.57 and a debt-to-equity ratio of 0.01. The company’s 50 day moving average is $0.76 and its 200-day moving average is $0.77. Retractable Technologies has a 12-month low of $0.56 and a 12-month high of $1.33.

Hedge Funds Weigh In On Retractable Technologies

A number of large investors have recently made changes to their positions in the stock. Wealthfront Advisers LLC bought a new stake in shares of Retractable Technologies during the 4th quarter valued at $1,748,000. PFG Investments LLC purchased a new position in Retractable Technologies during the 3rd quarter valued at about $27,000. Finally, Renaissance Technologies LLC increased its position in shares of Retractable Technologies by 9.4% during the fourth quarter. Renaissance Technologies LLC now owns 361,253 shares of the company’s stock valued at $249,000 after buying an additional 31,140 shares during the period. 7.58% of the stock is owned by institutional investors.

Retractable Technologies Company Profile

Retractable Technologies, Inc designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession in the United States, rest of North and South America, and internationally. The company offers VanishPoint insulin syringes; tuberculin, insulin, and allergy antigen syringes; small diameter tube adapters; blood collection tube holders; allergy trays; IV safety catheters; Patient Safe syringes and Luer Caps; VanishPoint blood collection sets; EasyPoint needles; and VanishPoint autodisable syringes.